Thigh Circumference Reduction Study

Inclusion Criteria: * Body Mass Index between 20 and 35 * Presence of cellulite grades II, III or IV according to GLD scale * Visible bi-lateral thigh fat Thigh area to be treated to measure at least 30.0mm in vertical fold, as measured with industry standard fat caliper * Subject must be able to read, understand and sign the Consent Form * Subject must adhere to the follow-up schedule and study instructions * Subject must adhere to the same diet and/or exercise routine throughout the study Exclusion Criteria: * Significant weight fluctuation (+/-10 lbs) in the past 6 months * Taking weight-loss medications/supplements * Participation in any other clinical study * Cellulite treatment within 3 months of the treatment * Surgical or non-surgical treatments to the target area in the last 12 months, e.g., liposuction * Prior treatment to the target area within the last 12 months * Arteriosclerosis or weakened blood vessels * Heart disease * Thromboembolic disease * Diagnosed or documented immune system disorders * Bleeding disorders. * Presence of uncontrolled hypertension * Taking prescription anticoagulants * History of keloid formation * Malignant tumors in the target area * Diabetes * Any disease or condition that could impair wound healing * Skin abnormalities in the target area, e.g., cuts, scrapes, wounds, scars * Infection in the target area * Implanted electrical device(s) * Pregnant or lactating